Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women

Metabolism: Clinical and Experimental

Volumn 56, Issue 12, 2007, Pages 1729-1734

  Carlson, Olga ^a   Martin, Bronwen ^a   Stote, Kim S ^b   Golden, Erin ^a   Maudsley, Stuart ^a   Najjar, Samer S ^a   Ferrucci, Luigi ^a   Ingram, Donald K ^a   Longo, Dan L ^a   Rumpler, William V ^b   Baer, David J ^b   Egan, Josephine ^a   Mattson, Mark P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GHRELIN; GLUCAGON; GLUCOSE; INSULIN; LEPTIN; RESISTIN;

ADULT; ARTICLE; CALORIC INTAKE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; ENERGY METABOLISM; FEMALE; FOOD INTAKE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN RESPONSE; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZATION; SEX DIFFERENCE;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CROSS-OVER STUDIES; ENERGY METABOLISM; FEEDING BEHAVIOR; FEMALE; GHRELIN; GLUCAGON; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; RESISTIN;

EID: 35848947224     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.07.018     Document Type: Article

References (38)

1. Arner P. Insulin resistance in type 2 diabetes-role of the adipokines. Curr Mol Med 5 (2005) 333-339
2. Aygencel G., Karamercan A., Akinci E., Demircan A., and Akeles A. Metabolic syndrome and its association with ischemic cerebrovascular disease. Adv Ther 23 (2006) 495-501
3. Schwartz E.A., and Reaven P.D. Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinol Metab Clin North Am 35 (2006) 525-549
4. Efendic S., Grill V., Luft R., and Wajngot A. Low insulin response: a marker of prediabetes. Adv Exp Med Biol 246 (1988) 167-174
5. Kanauchi M., Kawano T., Kanauchi K., and Saito Y. New "pre-diabetes" category and the metabolic syndrome in Japanese. Horm Metab Res 37 (2005) 622-626
6. Osei K., Rhinesmith S., Gaillard T., and Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 27 (2004) 1439-1446
7. Haring H.U., and Mehnert H. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia 36 (1993) 176-182
8. Hamann A., and Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 104 (1996) 293-300
9. Munzberg H., and Myers Jr. M.G. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8 (2005) 566-570
10. Koerner A., Kratzsch J., and Kiess W. Adipocytokines: leptin-the classical, resistin-the controversial, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19 (2005) 525-546
11. Duan W., Guo Z., Jiang H., Ware M., and Mattson M.P. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 144 (2003) 2446-2453
12. Nakagawa T., Ogawa Y., Ebihara K., Yamanaka M., Tsuchida A., Taiji M., et al. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance. Int J Obes Relat Metab Disord 27 (2003) 557-565
13. Ono M., Itakura Y., Nonomura T., Nakagawa T., Nakayama C., Taiji M., et al. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism 49 (2000) 129-133
14. Krabbe K.S., Nielsen A.R., Krogh-Madsen R., Plomgaard P., Rasmussen P., Erikstrup C., et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50 (2007) 431-438
15. Schless G.L., and Duncan G.G. The beneficial effect of intermittent total fasts on the glucose tolerance in obese diabetic patients. Metabolism 15 (1966) 98-102
16. Pedersen C.R., Hagemann I., Bock T., and Buschard K. Intermittent feeding and fasting reduces diabetes incidence in BB rats. Autoimmunity 30 (1999) 243-250
17. Anson R.M., Guo Z., de Cabo R., Iyun T., Rios M., Hagepanos A., et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci U S A 100 (2003) 6216-6220
18. Mattson M.P., and Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 16 (2005) 129-137
19. Mager D.E., Wan R., Brown M., Cheng A., Wareski P., Abernethy D.R., et al. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J 20 (2006) 631-637
20. Jenkins D.J., Wolever T.M., Vuksan V., et al. Nibbling versus gorging: metabolic advantages of increased meal frequency. N Engl J Med 321 (1989) 929-934
21. Keski-Rahkonen A., Kaprio J., Rissanen A., Virkkunen M., and Rose R.J. Breakfast skipping and health-compromising behaviors in adolescents and adults. Eur J Clin Nutr 57 (2003) 842-853
22. Farshchi H.R., Taylor M.A., and Macdonald I.A. Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J Clin Nutr 81 (2005) 388-396
23. Mattson M.P. The need for controlled studies of the effects of meal frequency on health. Lancet 365 (2005) 1978-1980
24. Nutrition and your health: dietary guidelines for Americans, 2005 Dietary Guidelines Advisory Committee Report, Research Recommendations; 2005. http://www.health.gov/DietaryGuidelines/dga2005/report/HTML/F_ResearchRec.htm.
25. Wan R., Camandola S., and Mattson M.P. Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. J Nutr 133 (2003) 1921-1929
26. Martin A., Normand S., Sothier M., Peyrat J., Louche-Pelissier C., and Laville M. Is advice for breakfast consumption justified? Results from a short-term dietary and metabolic experiment in young healthy men. Br J Nutr 84 (2000) 337-344
27. Heilbronn L.K., Smith S.R., Martin C.K., Anton S.D., and Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr 81 (2005) 69-73
28. Johnson J.B., Summer W., Cutler R.G., Martin B., Hyun D.H., Dixit V.D., et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 42 (2007) 665-674
29. Stote K.S., Baer D.J., Spears K., Paul D.R., Harris G.K., Rumpler W.V., et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal weight middle-aged men and women. Am J Clin Nutr 85 (2007) 981-988
30. Kim B.J., Carlson O.D., Jang H.J., Elahi D., Berry C., and Egan J.M. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab 90 (2005) 6665-6671
31. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
32. Kanauchi M., Yamano S., Kanauchi K., and Saito Y. Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. J Clin Endocrinol Metab 88 (2003) 3444-3446
33. Theodorakis M.J., Muller D.C., Carlson O., and Egan J.M. Assessment of insulin sensitivity and secretion indices from oral glucose tolerance testing in subjects with fasting euglycemia but impaired 2-hour plasma glucose. Metabolism 52 (2003) 1523-1524
34. Stumvoll M., Mitrakou A., Pimenta W., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301
35. Stumvoll M., Van Haeften T., Fritsche A., and Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24 (2001) 796-797
36. Segal K.R., Landt M., and Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45 (1996) 988-991
37. Henkel E., Menschikowski M., Koehler C., Leonhardt W., and Hanefeld M. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus. Metabolism 54 (2005) 1168-1173
38. Morgan L., Hampton S., Gibbs M., and Arendt J. Circadian aspects of postprandial metabolism. Chronobiol Int 20 (2003) 795-808